These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 23401547)

  • 1. Inhibition of the prostaglandin receptor EP2 following status epilepticus reduces delayed mortality and brain inflammation.
    Jiang J; Quan Y; Ganesh T; Pouliot WA; Dudek FE; Dingledine R
    Proc Natl Acad Sci U S A; 2013 Feb; 110(9):3591-6. PubMed ID: 23401547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of the prostaglandin EP2 receptor is neuroprotective and accelerates functional recovery in a rat model of organophosphorus induced status epilepticus.
    Rojas A; Ganesh T; Lelutiu N; Gueorguieva P; Dingledine R
    Neuropharmacology; 2015 Jun; 93():15-27. PubMed ID: 25656476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppressing pro-inflammatory prostaglandin signaling attenuates excitotoxicity-associated neuronal inflammation and injury.
    Jiang J; Yu Y; Kinjo ER; Du Y; Nguyen HP; Dingledine R
    Neuropharmacology; 2019 May; 149():149-160. PubMed ID: 30763657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of the prostaglandin E2 receptor EP2 prevents status epilepticus-induced deficits in the novel object recognition task in rats.
    Rojas A; Ganesh T; Manji Z; O'neill T; Dingledine R
    Neuropharmacology; 2016 Nov; 110(Pt A):419-430. PubMed ID: 27477533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic window for cyclooxygenase-2 related anti-inflammatory therapy after status epilepticus.
    Jiang J; Yang MS; Quan Y; Gueorguieva P; Ganesh T; Dingledine R
    Neurobiol Dis; 2015 Apr; 76():126-136. PubMed ID: 25600211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel Second-Generation EP2 Receptor Antagonist Reduces Neuroinflammation and Gliosis After Status Epilepticus in Rats.
    Rojas A; Amaradhi R; Banik A; Jiang C; Abreu-Melon J; Wang S; Dingledine R; Ganesh T
    Neurotherapeutics; 2021 Apr; 18(2):1207-1225. PubMed ID: 33410110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting prostaglandin receptor EP2 for adjunctive treatment of status epilepticus.
    Nagib MM; Yu Y; Jiang J
    Pharmacol Ther; 2020 May; 209():107504. PubMed ID: 32088247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral Myeloid Cell EP2 Activation Contributes to the Deleterious Consequences of Status Epilepticus.
    Varvel NH; Espinosa-Garcia C; Hunter-Chang S; Chen D; Biegel A; Hsieh A; Blackmer-Raynolds L; Ganesh T; Dingledine R
    J Neurosci; 2021 Feb; 41(5):1105-1117. PubMed ID: 33293358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small molecule antagonist reveals seizure-induced mediation of neuronal injury by prostaglandin E2 receptor subtype EP2.
    Jiang J; Ganesh T; Du Y; Quan Y; Serrano G; Qui M; Speigel I; Rojas A; Lelutiu N; Dingledine R
    Proc Natl Acad Sci U S A; 2012 Feb; 109(8):3149-54. PubMed ID: 22323596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A rat model of organophosphate-induced status epilepticus and the beneficial effects of EP2 receptor inhibition.
    Rojas A; Ganesh T; Wang W; Wang J; Dingledine R
    Neurobiol Dis; 2020 Jan; 133():104399. PubMed ID: 30818067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Annexin A1-derived peptide Ac
    Gimenes AD; Andrade BFD; Pinotti JVP; Oliani SM; Galvis-Alonso OY; Gil CD
    J Neuroinflammation; 2019 Feb; 16(1):32. PubMed ID: 30755225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EP2 receptor agonist ONO-AE1-259-01 attenuates pentylenetetrazole- and pilocarpine-induced seizures but causes hippocampal neurotoxicity.
    Santos AC; Temp FR; Marafiga JR; Pillat MM; Hessel AT; Ribeiro LR; Miyazato LG; Oliveira MS; Mello CF
    Epilepsy Behav; 2017 Aug; 73():180-188. PubMed ID: 28645087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostaglandin E2 EP2 receptor deletion attenuates intracerebral hemorrhage-induced brain injury and improves functional recovery.
    Leclerc JL; Lampert AS; Diller MA; Immergluck JB; Doré S
    ASN Neuro; 2015; 7(2):. PubMed ID: 25873308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EP2 Receptor Signaling Regulates Microglia Death.
    Fu Y; Yang MS; Jiang J; Ganesh T; Joe E; Dingledine R
    Mol Pharmacol; 2015 Jul; 88(1):161-70. PubMed ID: 25715797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resveratrol Treatment after Status Epilepticus Restrains Neurodegeneration and Abnormal Neurogenesis with Suppression of Oxidative Stress and Inflammation.
    Mishra V; Shuai B; Kodali M; Shetty GA; Hattiangady B; Rao X; Shetty AK
    Sci Rep; 2015 Dec; 5():17807. PubMed ID: 26639668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-administration of subtherapeutic diazepam enhances neuroprotective effect of COX-2 inhibitor, NS-398, after lithium pilocarpine-induced status epilepticus.
    Trandafir CC; Pouliot WA; Dudek FE; Ekstrand JJ
    Neuroscience; 2015 Jan; 284():601-610. PubMed ID: 25453777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transient inhibition of microsomal prostaglandin E synthase-1 after status epilepticus blunts brain inflammation and is neuroprotective.
    Yasmen N; Sluter MN; Li L; Yu Y; Jiang J
    Mol Brain; 2023 Jan; 16(1):14. PubMed ID: 36694204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The neuroprotective effect of perampanel in lithium-pilocarpine rat seizure model.
    Wu T; Ido K; Osada Y; Kotani S; Tamaoka A; Hanada T
    Epilepsy Res; 2017 Nov; 137():152-158. PubMed ID: 28624183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic window of opportunity for the neuroprotective effect of valproate versus the competitive AMPA receptor antagonist NS1209 following status epilepticus in rats.
    Langer M; Brandt C; Zellinger C; Löscher W
    Neuropharmacology; 2011; 61(5-6):1033-47. PubMed ID: 21736883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of EP
    Yousif NM; de Oliveira ACP; Brioschi S; Huell M; Biber K; Fiebich BL
    Glia; 2018 Apr; 66(4):708-724. PubMed ID: 29226424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.